Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07195071
NA

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

Sponsor: Columbia University

View on ClinicalTrials.gov

Summary

The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

1000

Start Date

2026-02-12

Completion Date

2028-12-31

Last Updated

2026-02-18

Healthy Volunteers

Yes

Interventions

DEVICE

Natera empower comprehensive hereditary cancer panel

Natera Empower Comprehensive Hereditary Cancer Panel to screen for hereditary cancers

DEVICE

Obstetrical carrier screening

Obstetrical carrier screening for genetic conditions

Locations (1)

Columbia University Irving Medical Center

New York, New York, United States